Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date19 Jul 2021 |
100 Clinical Results associated with Yunnan Tengyao Pharmaceutical Co Ltd.
0 Patents (Medical) associated with Yunnan Tengyao Pharmaceutical Co Ltd.
100 Deals associated with Yunnan Tengyao Pharmaceutical Co Ltd.
100 Translational Medicine associated with Yunnan Tengyao Pharmaceutical Co Ltd.